Guildford, United Kingdom

David F Horrobin


 

Average Co-Inventor Count = 1.6

ph-index = 24

Forward Citations = 3,069(Granted Patents)

Forward Citations (Not Self Cited) = 3,030(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Guildford, Surrey, GB (1993)
  • Lythe Hill Park, GB (1993)
  • Haslemere, GB (1988 - 1995)
  • Surrey, GB (1987 - 1999)
  • Guildford, Surrey, GU1 1BA, GB (2000)
  • Guildford, GB (1988 - 2003)
  • Scotland, GB (2003)
  • Stirling, GB (1999 - 2006)

Company Filing History:


Years Active: 1987-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Fatty Acid Treatment
Pharmaceutical Compositions
Therapeutic Compositions
Eicosapentaenoic Acid
Dietary Compositions
Triglycerides
Nicotinic Acid Esters
Bioactive Compounds
Internal Radiation Damage
Schizophrenia
Drug Delivery
Nutrition
70 patents (USPTO):Explore Patents

Title: **David F Horrobin: Innovator in Pain Treatment and Nutritional Therapy**

Introduction

David F Horrobin is a prominent inventor based in Guildford, GB, renowned for his significant contributions to the fields of pain treatment and nutritional therapy. With an impressive portfolio of 70 patents, Horrobin has made a notable impact on medical and dietary innovations.

Latest Patents

Among Horrobin's latest patents, two stand out prominently. The first is titled "Treatment of pain," which outlines a method of alleviating pain by the co-administration of an antidepressant alongside one or more precursors or inducers of neurotransmitters. The method specifically highlights amino acids such as L-phenylalanine, L-tyrosine, L-tryptophan, and L-DOPA, demonstrating a novel approach to pain management.

The second patent focuses on "Therapeutic and dietary compositions containing essential fatty acids and bioactive disulfides." This invention details compositions that include gamma-linolenic acid (GLA) and/or other essential fatty acids (EFAs) combined with thioctic acid or related compounds. These compositions are crafted to enhance therapy or nutrition, particularly aiming to improve cell membrane EFA concentration and alleviate complications arising from diabetes, such as impaired nerve function and blood flow.

Career Highlights

Throughout his career, David F Horrobin has worked with notable companies, including Scotia Holdings Plc and Efamol Holdings Plc. His endeavors in these organizations underscore his dedication to advancing health-related innovations and therapies.

Collaborations

Horrobin's ability to collaborate with fellow innovators has been instrumental in his success. Among his notable coworkers are Mehar S Manku and Philip Knowles, who have contributed to various projects aimed at enhancing therapeutic outcomes and nutritional benefits.

Conclusion

In conclusion, David F Horrobin stands as a noteworthy figure in the realms of pain treatment and nutritional therapy. His extensive patent portfolio reflects his commitment to innovation and improvement in healthcare, particularly through his recent advancements in therapeutic compositions. Horrobin's contributions continue to inspire ongoing research and development in these vital fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…